2018 American Transplant Congress » Concurrent Session: Late Breaking

4:30pm-4:42pm

The Results of the PRISM (Prediction of Rejection In Sensitized Patient Blood SaMples) Trial with a Novel Bioassay

F. Vincenti, A. Schroeder, S.-C. Hseish, J. Liberto, P. Towfighi, C. Koh, T. Sigdel, M. Sarwal.

4:42pm-4:54pm

Early Results from USHER: A Pilot Trial of Transplanting HCV-Infected Hearts into HCV-Negative Recipients Followed by Anti-Viral Therapy

R. McLean, P. P. Reese, M. Acker, P. Abt, A. Sicilia, N. Hornsby, P. Atluri, K. R. Reddy, E. Blumberg, V. Van Deerlin, D. S. Goldberg.

4:54pm-5:06pm

Interim Results of the kSORT in the SAILOR Randomized Multicenter Trial

P. Lindner,¹ A. Shroeder,² J. Ekberg,¹ S. Hsieh,² P. Towfighi,² I. Damm,² T. Sigdel,² M. Sarwal.²

5:06pm-5:18pm

T cell Phenotypes Predict Infectious Risk in Transplanted Children

E. T. Chambers,¹ R. Ettenger,² H.-J. Lee,¹ C. Chan,¹ L. Stempora,¹ B. Warshaw,³ P. Grimm,⁴ E. F. Reed,² M. Sarwal,⁵ A. Kirk.¹

5:18pm-5:30pm

Superior Renal Function with CNI-Free Everolimus over Standard CNI-Based Regimen: 18 Months Data from the Randomized, Multi-Center MANDELA Trial in De Novo Heart Transplant Recipients

M. J. Barten,¹ S. W. Hirt,¹ J. Garbade,¹ C. Bara,¹ A. Doesch,¹ C. Knosalla,¹ C. Grinninger,¹ J. Stypmann,¹ C. Sieder,² M. Junge,² U. Schulz.¹

5:30pm-5:42pm

Offspring Living Kidney Donors Should Not Be Ruled Out

X. Luo, A. Massie, C. Holscher, D. Segev.

5:42pm-5:54pm

Results of LITMUS (NCT 02541916): The Liver Immune Tolerance Bio Marker Utilization Study

A. Chruscinski,¹ V. Rojas-Luengas,¹ A. Issacher,¹ J. Luo,⁴ H. Yowanto,⁴ N. Selzner,¹ L. Lilly,¹ R. Smith,¹ E. Renner,¹ J. Zhang,¹ D. Grant,¹ O. Adeyi,¹ H. Atkins,² P. Juni,³ G. Levy.¹